Longboard Pharmaceuticals, Inc.
LBPHDelisted Dec 2, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001832168
Longboard Pharmaceuticals, Inc. was delisted on Dec 2, 2024; its insiders filed their last Form 4 on Dec 2, 2024; 125 institutions reported holding it in 13F filings for Q3 2024, worth $1.33B in total; Viking Global Investors was the only superinvestor holding it.
Q1 2023 vs. Q4 2022
How the institutions holding Longboard Pharmaceuticals, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 18 | 25 | +7 |
| Shares | 7.27M | 13.2M | +5.92M (+81.4%) |
| Value | $23.3M | $51.5M | +$28.1M (+120.5%) |
New holders (8)
Institutions that held Longboard Pharmaceuticals, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Point72 Asset Management, L.P. | 1,250,000 | $5.01M | 0.02% |
| Prosight Management, LP | 900,600 | $3.61M | 1.73% |
| UBS Oconnor LLC | 230,000 | $903.9K | 0.02% |
| Woodline Partners LP | 114,569 | $459.4K | 0.01% |
| CIBC Asset Management Inc | 56,125 | $225.1K | 0.00% |
| Manufacturers Life Insurance Company, The | 28,249 | $111.0K | 0.00% |
| Northern Trust Corp | 17,790 | $71.3K | 0.00% |
| Citigroup Inc | 2,768 | $10.9K | 0.00% |
Sold out (1)
Institutions that held Longboard Pharmaceuticals, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Bank of America Corp | 11 | $36 |